DB-11 & DB-05: Rewriting Neoadjuvant & Adjuvant HER2+ Breast Cancer Strategy - Dr. Alison Conlin & Dr. Heather McArthur episode artwork

EPISODE · Jan 6, 2026 · 34 MIN

DB-11 & DB-05: Rewriting Neoadjuvant & Adjuvant HER2+ Breast Cancer Strategy - Dr. Alison Conlin & Dr. Heather McArthur

from Community Health Media · host Community Health Media

Recorded live, this in-depth conversation features Dr. Alison Conlin and Dr. Heather McArthur as they break down the evolving role of antibody–drug conjugates in early-stage HER2-positive breast cancer.The discussion dives into DESTINY-Breast 11 and DESTINY-Breast 05, exploring how trastuzumab deruxtecan is challenging long-standing neoadjuvant and adjuvant paradigms. From pathologic complete response and invasive disease-free survival to toxicity management, ILD monitoring, and patient selection, this episode tackles how clinicians are balancing escalation and de-escalation in curative-intent care.A thoughtful, practical conversation on where HER2-positive treatment is headed — and how today’s decisions may redefine cure for high-risk patients.#BreastCancer #HER2Positive #Oncology #EarlyBreastCancer #DB11 #DB05 #AntibodyDrugConjugates #TrastuzumabDeruxtecan #NeoadjuvantTherapy #AdjuvantTherapy #ClinicalTrials #PrecisionOncology #MedicalOncology–Thanks for watching!Our podcasts are also available on: • Spotify - https://spotf.fi/chm-podcast • Amazon Music - https://amazn.so/chm-podcast • Apple Podcast - https://podcasts.apple.com/us/podcast/community-health-media/id1837428248 • Castbox - https://castbox.fm/vh/6735434 • Goodpods - https://goodpods.com/profile/chm-111066 • iHeartRadio - https://iheart.com/podcast/291542082 • Pocket Casts - https://pca.st/3ncdh11o–Community Health Media (CHM) is your full service healthcare communications partner, combining our production expertise with targeted multi-channel campaigns. We connect companies and healthcare brands with key opinion leaders, patients, and consumers through compelling content and live experiences.We’re an integrated marketing company that produces world-class content and curated peer to peer live experiences.We specialize in: • Peer to peer interviews, panels & round-tables • Curated live events & conferences • Professional in-depth content & research updates • Interactive learning modules & webinars • Live & on-demand webcasts & podcastsLearn more about us here - https://communityhealth.media

Episode metadata supplied by the publisher feed · Published Jan 6, 2026

Embed this episode

Ready to play

DB-11 & DB-05: Rewriting Neoadjuvant & Adjuvant HER2+ Breast Cancer Strategy - Dr. Alison Conlin & Dr. Heather McArthur

0:00 34:12

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Community Health Media?

This episode is 34 minutes long.

When was this Community Health Media episode published?

This episode was published on January 6, 2026.

Can I download this Community Health Media episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!